LC-MS/MS method development of aflibercept using Fab-selective proteolysis nSMOL technology

Posters | 2020 | ShimadzuInstrumentation
LC/TOF, LC/HRMS, LC/MS, LC/MS/MS, LC/QQQ
Industries
Clinical Research
Manufacturer
Shimadzu
Downloadable PDF for viewing
 

Similar PDF

Shimadzu Solutions for Biopharmaceutical - Application Notebook
LCMS™ Bioanalysis of Antibody Drugs Using Fab- Selective Proteolysis nSMOL – Part 7 - Tocilizumab Analysis -
LCMS Bioanalysis of Antibody Drugs Using Fab-Selective Proteolysis nSMOL - Trastuzumab analysis -
LCMS Bioanalysis of Antibody Drugs Using Fab-Selective Proteolysis nSMOL - Trastuzumab analysis